Search Media Items

Adult Hodgkin lymphoma treatment depends on the type (classical or nodular lymphocyte predominant) and includes chemotherapy and/or radiation therapy. Get comprehensive information on newly diagnosed and recurrent Hodgkin lymphoma treatment in this summary for clinicians.

Treatment for children with brain and spinal cord tumors is based on histology and location within the brain. For most of these tumors, an optimal regimen has not been determined, and enrollment onto clinical trials is encouraged. Get detailed information about these tumors in this clinician summary.

Colon cancer treatment often involves open surgical resection as the primary treatment for localized disease. Other modalities include chemotherapy, targeted therapy, radiation therapy, and local ablation. Get detailed information about colon cancer treatment in this summary for clinicians.

Osteosarcoma and malignant fibrous histiocytoma (MFH) of bone treatment depends on site, extent of disease, and grade. Treatment options include surgery, chemotherapy, radiation therapy, and targeted therapy. Get detailed treatment information for osteosarcoma and MFH in this summary for clinicians.

Non-Hodgkin lymphoma treatment options include chemotherapy, radiation, targeted therapy, plasmapheresis, surveillance, stem cell transplant, and surgery. Get comprehensive information on Non-Hodgkin classification and treatment in this clinician summary.

Rectal cancer treatment options include surgery, radiation therapy, chemoradiation, chemotherapy, targeted therapy, ablation, and surveillance. Get detailed information about the treatment of newly diagnosed and recurrent rectal cancer in this summary for clinicians.

Fatigue is the most common side effect of cancer treatment, but it can also be a presenting symptom. Fatigue has a negative impact on all areas of function and can last well beyond treatment. Get comprehensive information about fatigue and interventions in this summary for clinicians.

Gastrointestinal complications (e.g., constipation, bowel obstruction, diarrhea) can be tumor or treatment related and are common in cancer patients. Get detailed information about gastrointestinal complications and ways to manage them in this clinician summary.

Cancer pain can be a complication of cancer or its treatment, and can negatively affect the functional status and quality of life of cancer patients. Get comprehensive, practical information on the screening, assessment, and management of cancer-related pain in this summary for clinicians.

Depression, secondary to stress and emotional upset, can occur in adults and children with cancer. Get comprehensive information about assessing depression in patients, interventions, and more in this summary for clinicians.

Esophageal cancer treatment options include surgery alone for very early disease and add chemotherapy and radiation therapy for more advanced cases. Get detailed information about the treatment of newly diagnosed and recurrent esophageal cancer in this summary for clinicians.

Hot flashes and night sweats can be cancer or treatment related and occur commonly in both women and men. Get information on hormonal and nonhormonal agents, cognitive and behavioral methods, and integrative medicine treatment options in this clinician summary.

Male breast cancer treatment may include surgery with or without radiation therapy, chemotherapy, endocrine therapy, and/or HER2-directed therapy. Get detailed information about the diagnosis and treatment of newly diagnosed and recurrent male breast cancer in this summary for clinicians.

Sleep disorders (e.g., insomnias, sleep apnea, hypersomnias, parasomnias, and problems with circadian rhythm) are common in people with cancer. Get detailed information about the causes and management of the major sleep disorders in this summary for clinicians.

Treatment-related nausea and vomiting (acute, delayed, anticipatory, breakthrough, refractory, and chronic) are of paramount concern in cancer care. Get detailed information about prevention and treatment approaches for treatment-related nausea and vomiting in this summary for clinicians.